PRP Injections for Joint Pain: What the Science Says

Joint pain is one of the leading reasons men reduce their activity levels, abandon training programs, and accept a gradual erosion of physical capacity. Conventional options — NSAIDs, corticosteroid injections, and eventually surgery — address symptoms without addressing the underlying biological deficit. Platelet-rich plasma therapy takes a different approach: it uses your own blood's growth factors to actively stimulate tissue repair and remodeling at the injury site. The question isn't whether PRP sounds promising. It's whether the clinical evidence justifies its use for your specific condition.

What Is Platelet-Rich Plasma?

Platelet-rich plasma is prepared from a sample of your own blood. The blood is centrifuged to separate its components — red blood cells, white blood cells, plasma, and platelets. The platelet-rich plasma fraction, which contains a concentration of platelets 3–8 times higher than normal blood, is then extracted and injected into the treatment site.

Platelets are small cell fragments best known for their role in blood clotting — but their function goes far beyond hemostasis. Platelets contain dense granules packed with growth factors that are released at sites of tissue injury. These growth factors include platelet-derived growth factor (PDGF), transforming growth factor beta (TGF-β), vascular endothelial growth factor (VEGF), and insulin-like growth factor (IGF-1). Each of these plays a specific role in tissue repair, cell proliferation, and new blood vessel formation.

By concentrating these growth factors and delivering them directly to a damaged joint or tendon, PRP amplifies the body's natural healing signal at the precise location where repair is needed. In chronically injured tissue — where the normal healing response has stalled — this concentrated growth factor delivery can restart the repair process.

The Evidence for Knee Osteoarthritis

Knee osteoarthritis is where PRP has the most substantial clinical evidence base. Multiple randomized controlled trials and systematic reviews have examined PRP for knee OA, with generally favorable findings — particularly for mild-to-moderate disease.

A 2021 meta-analysis published in the American Journal of Sports Medicine reviewed 18 RCTs comparing PRP to corticosteroids and hyaluronic acid for knee OA. PRP showed superior outcomes at 6 and 12 months in both pain reduction and functional improvement, with corticosteroids showing better short-term pain relief but declining effectiveness beyond 3 months. A 2023 Cochrane review found moderate-certainty evidence that PRP reduces pain and improves function compared to saline or hyaluronic acid at 12 months.

PRP does not reverse structural cartilage loss — it's not a cure for advanced osteoarthritis. But for men with mild-to-moderate knee OA who want to reduce pain, improve function, and potentially slow disease progression without surgery, PRP represents a compelling option with an improving evidence base.

Shoulder: Rotator Cuff Tendinopathy and Partial Tears

The rotator cuff is among the most commonly injured structures in active men. Chronic rotator cuff tendinopathy — degeneration without frank tearing — responds particularly well to PRP. The tendon's inherently poor blood supply limits its natural healing capacity, making PRP's angiogenic growth factors especially valuable.

For partial rotator cuff tears, evidence is mixed but trending positive for leukocyte-rich PRP formulations. A 2020 study in Orthopaedic Journal of Sports Medicine found that PRP injection combined with a structured rehabilitation program reduced pain and improved shoulder function scores significantly compared to rehabilitation alone at 6-month follow-up.

PRP is generally not appropriate as a primary treatment for complete rotator cuff tears — these typically require surgical repair. But for the substantial population of men with partial tears or chronic tendinopathy who want to avoid or delay surgery, PRP is worth a serious clinical evaluation.

Hip: Labral Injuries and Early Osteoarthritis

Hip joint pathology is less studied than knee, but the available data on PRP for hip osteoarthritis and labral injuries is encouraging. A 2019 systematic review found that intra-articular PRP injection for hip OA produced significant pain reduction and functional improvement at 6 and 12 months, with an effect size comparable to that seen in knee OA trials.

Hip labral tears — common in men who train in high-impact activities — are a more complex picture. PRP injected near the labrum may reduce inflammation and pain, but frank labral tears typically require surgical intervention for structural restoration. PRP is most useful here as a post-surgical adjunct to support healing, or for management of pain in patients who are not surgical candidates.

PRP Formulations: Not All Are Equal

One important complexity in interpreting PRP research is that "PRP" is not a standardized product. Different preparation methods produce significantly different concentrations of platelets, growth factors, white blood cells, and red blood cells. Leukocyte-rich PRP (LR-PRP) has higher concentrations of white blood cells and inflammatory mediators, which may be beneficial for tendon pathology but potentially harmful for intra-articular joint injections. Leukocyte-poor PRP (LP-PRP) is generally preferred for joint injections.

This variability is one reason the PRP literature contains conflicting results — studies comparing different preparation methods are essentially comparing different products. Choosing a provider who understands PRP formulation and uses validated preparation protocols matters significantly for outcomes.

Who Is an Ideal Candidate?

PRP tends to produce the best results in patients who:

• Have mild-to-moderate osteoarthritis (Kellgren-Lawrence grade 1–3)
• Have chronic tendinopathy that has not responded to physical therapy or corticosteroids
• Are not taking blood thinners or NSAIDs regularly (these interfere with platelet function)
• Have realistic expectations — PRP is a biological process, not an instant fix
• Are willing to commit to a rehabilitation program alongside injections

PRP is generally not appropriate for active joint infections, blood disorders that affect platelet function, active cancer, or advanced arthritis (grade 4) where joint replacement is the appropriate intervention.

What to Expect at Revive

PRP preparation takes approximately 30 minutes in the clinic. A blood draw is processed through centrifugation, and the PRP fraction is prepared for injection. The injection itself takes only a few minutes and is performed with ultrasound guidance when appropriate to ensure accurate placement. Local anesthesia is used to minimize discomfort.

Most patients experience some soreness at the injection site for 3–7 days post-injection — this is a normal inflammatory response that precedes the healing process. Avoid NSAIDs during this period, as they can blunt the platelet-mediated repair response. Most protocols involve 2–3 injections spaced 4–6 weeks apart. Results continue to develop over 3–6 months as tissue remodeling progresses.